Exact Mass: 791.489

Exact Mass Matches: 791.489

Found 81 metabolites which its exact mass value is equals to given mass value 791.489, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Ascomycin

(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R ,19R,26aS)-8-Ethyl-5,6,8,11,12,13,14,15,16,17,18,1 9,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[(1E )-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetrameth yl-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)tetrone

C43H69NO12 (791.482)


Ascomycin is a macrolide that is produced by the fermentation of Streptomyces hygroscopicus and exhibits strong immunosuppressant properties. It has a role as an immunosuppressive agent, an antifungal agent and a bacterial metabolite. It is a macrolide, an ether, a lactol and a secondary alcohol. Ascomycin is a natural product found in Streptomyces clavuligerus, Streptomyces hygroscopicus, and Streptomyces ascomycinicus with data available. A macrolide that is produced by the fermentation of Streptomyces hygroscopicus and exhibits strong immunosuppressant properties. D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Ascomycin (Immunomycin; FR-900520; FK520) is an ethyl analog of Tacrolimus (FK506) with strong immunosuppressant properties. Ascomycin is also a macrocyclic polyketide antibiotic with multiple biological activities such as anti-malarial, anti-fungal and anti-spasmodic. Ascomycin prevents graft rejection and has potential for varying skin ailments research[1][2].

   

ascomycin

17-ethyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0⁴,⁹]octacos-18-ene-2,3,10,16-tetrone

C43H69NO12 (791.482)


   

PE(15:0/6 keto-PGF1alpha)

(2-aminoethoxy)[(2R)-2-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoyl}oxy)-3-(pentadecanoyloxy)propoxy]phosphinic acid

C40H74NO12P (791.4948)


PE(15:0/6 keto-PGF1alpha) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(15:0/6 keto-PGF1alpha), in particular, consists of one chain of one pentadecanoyl at the C-1 position and one chain of 6-Keto-prostaglandin F1alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PE(6 keto-PGF1alpha/15:0)

(2-aminoethoxy)[(2R)-3-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoyl}oxy)-2-(pentadecanoyloxy)propoxy]phosphinic acid

C40H74NO12P (791.4948)


PE(6 keto-PGF1alpha/15:0) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(6 keto-PGF1alpha/15:0), in particular, consists of one chain of one 6-Keto-prostaglandin F1alpha at the C-1 position and one chain of pentadecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PE(15:0/TXB2)

(2-aminoethoxy)[(2R)-2-{[(5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoyl]oxy}-3-(pentadecanoyloxy)propoxy]phosphinic acid

C40H74NO12P (791.4948)


PE(15:0/TXB2) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(15:0/TXB2), in particular, consists of one chain of one pentadecanoyl at the C-1 position and one chain of Thromboxane B2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PE(TXB2/15:0)

(2-aminoethoxy)[(2R)-3-{[(5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoyl]oxy}-2-(pentadecanoyloxy)propoxy]phosphinic acid

C40H74NO12P (791.4948)


PE(TXB2/15:0) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(TXB2/15:0), in particular, consists of one chain of one Thromboxane B2 at the C-1 position and one chain of pentadecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PS(16:1(9Z)/18:1(12Z)-2OH(9,10))

(2S)-2-amino-3-({[(2R)-2-{[(9S,10S,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-3-[(9Z)-hexadec-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)propanoic acid

C40H74NO12P (791.4948)


PS(16:1(9Z)/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidylserine (PS). Oxidized phosphatidylserines are glycerophospholipids in which a phosphorylserine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylserines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PS(16:1(9Z)/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one 9Z-hexadecenoyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PSs can be synthesized via three different routes. In one route, the oxidized PS is synthetized de novo following the same mechanisms as for PSs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PS backbone, mainly through the action of LOX (PMID: 33329396).

   

PS(18:1(12Z)-2OH(9,10)/16:1(9Z))

(2S)-2-amino-3-({[(2R)-3-{[(9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-2-[(9Z)-hexadec-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)propanoic acid

C40H74NO12P (791.4948)


PS(18:1(12Z)-2OH(9,10)/16:1(9Z)) is an oxidized phosphatidylserine (PS). Oxidized phosphatidylserines are glycerophospholipids in which a phosphorylserine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylserines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PS(18:1(12Z)-2OH(9,10)/16:1(9Z)), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of 9Z-hexadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PSs can be synthesized via three different routes. In one route, the oxidized PS is synthetized de novo following the same mechanisms as for PSs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PS backbone, mainly through the action of LOX (PMID: 33329396).

   

Conglutinin

2-formamido-3-methyl-N-[20-methyl-3,16-bis(2-methylpropyl)-2,5,12,15,18,22-hexaoxo-13-(propan-2-yl)-21-oxa-1,4,10,11,14,17,27-heptaazatricyclo[21.4.0.0⁶,¹¹]heptacosan-19-yl]pentanamide

C38H65N9O9 (791.4905)


Isolated from bovine serum. Ca2(+)-dependent lectin. Conglutinin is a collectin protein. Conglutinin is found in animal foods. Isolated from bovine serum. Ca2(+)-dependent lectin

   
   

PE(15:0/6 keto-PGF1alpha)

PE(15:0/6 keto-PGF1alpha)

C40H74NO12P (791.4948)


   

PE(6 keto-PGF1alpha/15:0)

PE(6 keto-PGF1alpha/15:0)

C40H74NO12P (791.4948)


   
   
   

PS(16:1(9Z)/18:1(12Z)-2OH(9,10))

PS(16:1(9Z)/18:1(12Z)-2OH(9,10))

C40H74NO12P (791.4948)


   

PS(18:1(12Z)-2OH(9,10)/16:1(9Z))

PS(18:1(12Z)-2OH(9,10)/16:1(9Z))

C40H74NO12P (791.4948)


   

3-O-[alpha-L-arabinopyranosyl-(1->6)]-2-acetamido-2-deoxy-beta-D-glucopyranosyl oleanolic acid

3-O-[alpha-L-arabinopyranosyl-(1->6)]-2-acetamido-2-deoxy-beta-D-glucopyranosyl oleanolic acid

C43H69NO12 (791.482)


A natural product found in Albizia inundata.

   
   
   

SHexCer 16:2;2O/18:1;O

SHexCer 16:2;2O/18:1;O

C40H73NO12S (791.4853)


   

SHexCer 13:2;2O/21:1;O

SHexCer 13:2;2O/21:1;O

C40H73NO12S (791.4853)


   

SHexCer 16:3;2O/18:0;O

SHexCer 16:3;2O/18:0;O

C40H73NO12S (791.4853)


   

SHexCer 19:2;2O/15:1;O

SHexCer 19:2;2O/15:1;O

C40H73NO12S (791.4853)


   

SHexCer 20:2;2O/14:1;O

SHexCer 20:2;2O/14:1;O

C40H73NO12S (791.4853)


   

SHexCer 12:2;2O/22:1;O

SHexCer 12:2;2O/22:1;O

C40H73NO12S (791.4853)


   

SHexCer 18:1;2O/16:2;O

SHexCer 18:1;2O/16:2;O

C40H73NO12S (791.4853)


   

SHexCer 12:1;2O/22:2;O

SHexCer 12:1;2O/22:2;O

C40H73NO12S (791.4853)


   

SHexCer 19:3;2O/15:0;O

SHexCer 19:3;2O/15:0;O

C40H73NO12S (791.4853)


   

SHexCer 15:3;2O/19:0;O

SHexCer 15:3;2O/19:0;O

C40H73NO12S (791.4853)


   

SHexCer 14:1;2O/20:2;O

SHexCer 14:1;2O/20:2;O

C40H73NO12S (791.4853)


   

SHexCer 18:2;2O/16:1;O

SHexCer 18:2;2O/16:1;O

C40H73NO12S (791.4853)


   

SHexCer 15:2;2O/19:1;O

SHexCer 15:2;2O/19:1;O

C40H73NO12S (791.4853)


   

SHexCer 18:3;2O/16:0;O

SHexCer 18:3;2O/16:0;O

C40H73NO12S (791.4853)


   

SHexCer 20:3;2O/14:0;O

SHexCer 20:3;2O/14:0;O

C40H73NO12S (791.4853)


   

SHexCer 14:2;2O/20:1;O

SHexCer 14:2;2O/20:1;O

C40H73NO12S (791.4853)


   

SHexCer 21:3;2O/13:0;O

SHexCer 21:3;2O/13:0;O

C40H73NO12S (791.4853)


   

SHexCer 17:3;2O/17:0;O

SHexCer 17:3;2O/17:0;O

C40H73NO12S (791.4853)


   

SHexCer 22:2;2O/12:1;O

SHexCer 22:2;2O/12:1;O

C40H73NO12S (791.4853)


   

SHexCer 21:2;2O/13:1;O

SHexCer 21:2;2O/13:1;O

C40H73NO12S (791.4853)


   

SHexCer 22:3;2O/12:0;O

SHexCer 22:3;2O/12:0;O

C40H73NO12S (791.4853)


   

SHexCer 14:3;2O/20:0;O

SHexCer 14:3;2O/20:0;O

C40H73NO12S (791.4853)


   

SHexCer 10:1;2O/24:2;O

SHexCer 10:1;2O/24:2;O

C40H73NO12S (791.4853)


   

SHexCer 16:1;2O/18:2;O

SHexCer 16:1;2O/18:2;O

C40H73NO12S (791.4853)


   

PI-Cer 14:3;2O/20:0;O

PI-Cer 14:3;2O/20:0;O

C40H74NO12P (791.4948)


   

PI-Cer 19:2;2O/15:1;O

PI-Cer 19:2;2O/15:1;O

C40H74NO12P (791.4948)


   

PI-Cer 18:1;2O/16:2;O

PI-Cer 18:1;2O/16:2;O

C40H74NO12P (791.4948)


   

PI-Cer 12:2;2O/22:1;O

PI-Cer 12:2;2O/22:1;O

C40H74NO12P (791.4948)


   

PI-Cer 16:1;2O/18:2;O

PI-Cer 16:1;2O/18:2;O

C40H74NO12P (791.4948)


   

PI-Cer 17:3;2O/17:0;O

PI-Cer 17:3;2O/17:0;O

C40H74NO12P (791.4948)


   

PI-Cer 14:2;2O/20:1;O

PI-Cer 14:2;2O/20:1;O

C40H74NO12P (791.4948)


   

PI-Cer 14:1;2O/20:2;O

PI-Cer 14:1;2O/20:2;O

C40H74NO12P (791.4948)


   

PI-Cer 18:2;2O/16:1;O

PI-Cer 18:2;2O/16:1;O

C40H74NO12P (791.4948)


   

PI-Cer 15:3;2O/19:0;O

PI-Cer 15:3;2O/19:0;O

C40H74NO12P (791.4948)


   

PI-Cer 12:1;2O/22:2;O

PI-Cer 12:1;2O/22:2;O

C40H74NO12P (791.4948)


   

PI-Cer 16:2;2O/18:1;O

PI-Cer 16:2;2O/18:1;O

C40H74NO12P (791.4948)


   

PI-Cer 22:3;2O/12:0;O

PI-Cer 22:3;2O/12:0;O

C40H74NO12P (791.4948)


   

PI-Cer 16:3;2O/18:0;O

PI-Cer 16:3;2O/18:0;O

C40H74NO12P (791.4948)


   

PI-Cer 20:2;2O/14:1;O

PI-Cer 20:2;2O/14:1;O

C40H74NO12P (791.4948)


   

PI-Cer 21:2;2O/13:1;O

PI-Cer 21:2;2O/13:1;O

C40H74NO12P (791.4948)


   

PI-Cer 15:2;2O/19:1;O

PI-Cer 15:2;2O/19:1;O

C40H74NO12P (791.4948)


   

PI-Cer 22:2;2O/12:1;O

PI-Cer 22:2;2O/12:1;O

C40H74NO12P (791.4948)


   

PI-Cer 19:3;2O/15:0;O

PI-Cer 19:3;2O/15:0;O

C40H74NO12P (791.4948)


   

PI-Cer 13:2;2O/21:1;O

PI-Cer 13:2;2O/21:1;O

C40H74NO12P (791.4948)


   

PI-Cer 20:3;2O/14:0;O

PI-Cer 20:3;2O/14:0;O

C40H74NO12P (791.4948)


   

PI-Cer 18:3;2O/16:0;O

PI-Cer 18:3;2O/16:0;O

C40H74NO12P (791.4948)


   

PI-Cer 21:3;2O/13:0;O

PI-Cer 21:3;2O/13:0;O

C40H74NO12P (791.4948)


   
   
   
   

PE P-42:12 or PE O-42:13

PE P-42:12 or PE O-42:13

C47H70NO7P (791.489)


   
   
   
   
   
   

IPC 14:2;O2/20:1;O

IPC 14:2;O2/20:1;O

C40H74NO12P (791.4948)


   

IPC 16:2;O2/18:1;O

IPC 16:2;O2/18:1;O

C40H74NO12P (791.4948)


   
   

(2r,3r)-2-[(hydroxymethylidene)amino]-3-methyl-n-[(3r,6s,13r,16r,19r,20s,23s)-5,15,18-trihydroxy-13-isopropyl-20-methyl-3,16-bis(2-methylpropyl)-2,12,22-trioxo-21-oxa-1,4,10,11,14,17,27-heptaazatricyclo[21.4.0.0⁶,¹¹]heptacosa-4,14,17-trien-19-yl]pentanimidic acid

(2r,3r)-2-[(hydroxymethylidene)amino]-3-methyl-n-[(3r,6s,13r,16r,19r,20s,23s)-5,15,18-trihydroxy-13-isopropyl-20-methyl-3,16-bis(2-methylpropyl)-2,12,22-trioxo-21-oxa-1,4,10,11,14,17,27-heptaazatricyclo[21.4.0.0⁶,¹¹]heptacosa-4,14,17-trien-19-yl]pentanimidic acid

C38H65N9O9 (791.4905)


   

2-[(hydroxymethylidene)amino]-3-methyl-n-[5,15,18-trihydroxy-13-isopropyl-20-methyl-3,16-bis(2-methylpropyl)-2,12,22-trioxo-21-oxa-1,4,10,11,14,17,27-heptaazatricyclo[21.4.0.0⁶,¹¹]heptacosa-4,14,17-trien-19-yl]pentanimidic acid

2-[(hydroxymethylidene)amino]-3-methyl-n-[5,15,18-trihydroxy-13-isopropyl-20-methyl-3,16-bis(2-methylpropyl)-2,12,22-trioxo-21-oxa-1,4,10,11,14,17,27-heptaazatricyclo[21.4.0.0⁶,¹¹]heptacosa-4,14,17-trien-19-yl]pentanimidic acid

C38H65N9O9 (791.4905)


   

(1r,9s,12s,13r,14s,17r,18z,21s,23s,24r,25s,27r)-17-ethyl-1,14-dihydroxy-12-[(1e)-1-[(1r,4r)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0⁴,⁹]octacos-18-ene-2,3,10,16-tetrone

(1r,9s,12s,13r,14s,17r,18z,21s,23s,24r,25s,27r)-17-ethyl-1,14-dihydroxy-12-[(1e)-1-[(1r,4r)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0⁴,⁹]octacos-18-ene-2,3,10,16-tetrone

C43H69NO12 (791.482)